Filing Details
- Accession Number:
- 0001127602-15-015037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-23 16:55:51
- Reporting Period:
- 2015-04-21
- Filing Date:
- 2015-04-23
- Accepted Time:
- 2015-04-23 16:55:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1216070 | H Seth Hoogasian | 81 Wyman Street Waltham MA 02451 | Sr. Vp, Gen. Counsel & Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-04-21 | 1,813 | $49.49 | 41,801 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-04-21 | 8,325 | $54.97 | 50,126 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-04-21 | 13,256 | $135.00 | 36,870 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-04-21 | 1,813 | $0.00 | 1,813 | $49.49 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-04-21 | 8,325 | $0.00 | 8,325 | $54.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-03-05 | 2017-03-05 | No | 4 | M | Direct |
| 0 | 2018-02-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 407 | Indirect | By 401(k) |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2015.
- The option vested in four equal installments on March 5, 2012, 2013, 2014 and 2015.
- The option vested in four equal installments on February 23, 2012, 2013, 2014 and 2015.
Billionaire Hedge Funds
